Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1093 | 993 | 1093 | 1184 | 1263 | 1813 |
Fund Return | 9.26% | -0.68% | 9.26% | 5.8% | 4.78% | 6.13% |
Place in category | 252 | 291 | 252 | 228 | 166 | 93 |
% in Category | 40 | 47 | 40 | 42 | 35 | 26 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Legal General US Index Trust F Acc | 580.49K | 26.93 | 10.90 | 14.79 | ||
Legal General US Index Trust F Dist | 24.52K | 26.85 | 10.88 | 14.78 | ||
Legal General US Index Trust I Acc | 1.75B | 27.16 | 11.15 | 15.07 | ||
Legal General US Index Trust I Dist | 1.77B | 27.16 | 11.15 | 15.07 | ||
Legal General US Index Trust C Acc | 3.73B | 27.25 | 11.20 | 15.12 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Index Unit Trust Accumulation | 15.26B | 9.33 | 5.76 | 6.10 | ||
All Share Index Unit Trust Income | 15.26B | 9.33 | 5.75 | 6.09 | ||
VG UK Plus GBP Accumulation | 15.26B | 9.34 | 5.76 | 6.12 | ||
VG UK Institutional Plus GBP Income | 15.26B | 9.34 | 5.75 | 6.11 | ||
UK Equity Tracker Fund D Acc | 11.63B | 9.28 | 6.08 | 6.28 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AstraZeneca | GB0009895292 | 7.02 | 11,344.0 | +0.27% | |
Shell | GB00BP6MXD84 | 6.75 | 32.16 | +0.47% | |
HSBC | GB0005405286 | 5.59 | 845.70 | +0.65% | |
Unilever | GB00B10RZP78 | 4.89 | 55.36 | -0.65% | |
Relx | GB00B2B0DG97 | 2.83 | 4,025.00 | +0.02% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review